Synthetic Cannabinoids, Opioids, and Polydrug Use: Clinical Implications

Abstract

In Chapter 10, Mariya Prilutskaya, Justin Yang, and Andres Roman-Urrestarazu discuss synthetic cannabinoids, opioids, and polydrug abuse and their implications for clinical management. They discuss the interaction of synthetic cannabinoids with other drugs in individuals with polydrug substance misuse disorder and how this might be an increasingly prevalent problem in different clinical settings, especially during the management of withdrawal symptoms. They also discuss therapeutic and treatment possibilities, discussing in detail how this might be different to what has traditionally been provided to individuals with polysubstance misuse disorders by clinicians.

Publication
Handbook of Novel Psychoactive Substances: What Clinicians Should Know About NPS (Routledge)
Date
Links